Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
NCT03752905Phase 2Completed
- Sponsor
- Phoenix Tissue Repair
- Start
- Jan 2019
- Primary completion
- Nov 2020
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of RIN-002 in Recessive Dystrophic Epidermolysis Bullosa (RDEB), sponsored by Phoenix Tissue Repair. Started Jan 2019; status: completed.
02
Drugs
RIN-002
03
Conditions
Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Beyond the preview
Go deeper on NCT03752905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03752905.